
Keywords: Cilostazol; Obesity; AngiotensinII; Diastolic dysfunction; HFpEF; TGF-β; PKM2; Ciloz; Cilostazol; AngII; AngiotensinII; HFD; High Fat Diet; FS; Fraction Shortening; EF; Ejection Fraction; HFpEF; Heart failure with Preserved Ejection Fraction; PKM2; Pyruv